Home  »  News   »  CTI BioPharma Corp. (CTIC): Does this stock hold t...

CTI BioPharma Corp. (CTIC): Does this stock hold the most enticing factor today?

For the readers interested in the stock health of CTI BioPharma Corp. (CTIC). It is currently valued at $5.95. When the transactions were called off in the previous session, Stock hit the highs of $5.99, after setting-off with the price of $5.82. Company’s stock value dipped to $5.81 during the trading on the day. When the trading was stopped its value was $5.92.Recently in News on January 5, 2023, CTI BioPharma to Present at the 41st Annual J.P. Morgan Healthcare Conference. CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will present a corporate overview at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco. You can read further details here

CTI BioPharma Corp. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $6.07 on 01/03/23, with the lowest value was $5.21 for the same time period, recorded on 01/09/23.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


CTI BioPharma Corp. (CTIC) full year performance was 154.08%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, CTI BioPharma Corp. shares are logging -23.65% during the 52-week period from high price, and 227.20% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.82 and $7.80.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1240199 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the CTI BioPharma Corp. (CTIC) recorded performance in the market was -1.50%, having the revenues showcasing 27.31% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 725.38M, as it employees total of 121 workers.

Market experts do have their say about CTI BioPharma Corp. (CTIC)

During the last month, 0 analysts gave the CTI BioPharma Corp. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 5.61, with a change in the price was noted -0.13. In a similar fashion, CTI BioPharma Corp. posted a movement of -2.05% for the period of last 100 days, recording 3,398,974 in trading volumes.

Technical breakdown of CTI BioPharma Corp. (CTIC)

Raw Stochastic average of CTI BioPharma Corp. in the period of last 50 days is set at 79.90%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 89.60%. In the last 20 days, the company’s Stochastic %K was 80.35% and its Stochastic %D was recorded 67.37%.

Bearing in mind the latest performance of CTI BioPharma Corp., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -1.50%. Additionally, trading for the stock in the period of the last six months notably improved by 0.17%, alongside a boost of 154.08% for the period of the last 12 months. The shares increased approximately by 1.89% in the 7-day charts and went down by 6.28% in the period of the last 30 days. Common stock shares were driven by 27.31% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts